|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 173 of 179 found articles
| Title: |
179TiP EMERALD: A randomized, open-label, phase III trial to evaluate the efficacy and safety of elacestrant (RAD1901), a novel oral selective estrogen receptor degrader (SERD), vs investigator’s choice of endocrine therapy for ER+/HER2- advanced breast cancer following CDK4/6 inhibitor therapy |
| Author: |
Bardia, A. Lu, J. Kaklamani, V. Jung, J. Anderson-Villaluz, A.T. Conlan, M.G. Bidard, F-C. Cortés, J. Aftimos, P.G. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 31 () nr. S2 pages S80 |
| Year: |
2020 |
| Contents: | |
| Publisher: |
The Authors |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 173 of 179 found articles
| << previous | next >> |